Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ETNB |
---|---|---|
09:32 ET | 24248 | 8.83 |
09:33 ET | 200 | 8.735 |
09:35 ET | 500 | 8.7 |
09:37 ET | 19684 | 8.535 |
09:39 ET | 4178 | 8.4 |
09:42 ET | 7532 | 8.332 |
09:44 ET | 1900 | 8.24 |
09:46 ET | 2300 | 8.2 |
09:48 ET | 41101 | 8.09 |
09:50 ET | 4429 | 8.15 |
09:51 ET | 5102 | 8.125 |
09:53 ET | 2356 | 8.07 |
09:55 ET | 9498 | 8.1473 |
09:57 ET | 1805 | 8.19 |
10:00 ET | 937 | 8.21 |
10:02 ET | 1305 | 8.17 |
10:04 ET | 1426 | 8.22 |
10:06 ET | 729 | 8.205 |
10:08 ET | 16443 | 8.17 |
10:09 ET | 22825 | 8.055 |
10:11 ET | 2081 | 8.08 |
10:13 ET | 1047 | 8.07 |
10:15 ET | 14344 | 8.05 |
10:18 ET | 12093 | 7.97 |
10:20 ET | 4027 | 8.055 |
10:22 ET | 1798 | 8.01 |
10:24 ET | 1200 | 8 |
10:26 ET | 7763 | 8.01 |
10:27 ET | 4733 | 8.005 |
10:29 ET | 2370 | 8 |
10:31 ET | 488 | 7.97 |
10:33 ET | 5580 | 7.99 |
10:36 ET | 1406 | 7.98 |
10:38 ET | 506 | 7.955479 |
10:40 ET | 5505 | 8.03 |
10:42 ET | 2000 | 8.06 |
10:44 ET | 14992 | 8.09 |
10:45 ET | 1927 | 8.125 |
10:47 ET | 500 | 8.1075 |
10:49 ET | 597 | 8.105 |
10:51 ET | 3115 | 8.12 |
10:54 ET | 3567 | 8.05 |
10:56 ET | 5213 | 8 |
10:58 ET | 3311 | 8.021177 |
11:00 ET | 5555 | 8.03 |
11:02 ET | 2341 | 8.005 |
11:03 ET | 7847 | 8 |
11:05 ET | 571 | 8.005 |
11:07 ET | 1528 | 8.005 |
11:09 ET | 200 | 8.01 |
11:12 ET | 1250 | 8.01 |
11:14 ET | 9330 | 8.025 |
11:16 ET | 1949 | 8.0598 |
11:18 ET | 13950 | 8.08 |
11:20 ET | 2847 | 8.03 |
11:21 ET | 1180 | 8.08 |
11:23 ET | 651 | 8.108825 |
11:25 ET | 600 | 8.14 |
11:27 ET | 1588 | 8.11 |
11:30 ET | 4089 | 8.1 |
11:32 ET | 1882 | 8.12 |
11:34 ET | 700 | 8.13 |
11:36 ET | 1664 | 8.1311 |
11:38 ET | 3350 | 8.125 |
11:39 ET | 3172 | 8.14 |
11:41 ET | 4726 | 8.21 |
11:43 ET | 4202 | 8.21 |
11:45 ET | 200 | 8.24 |
11:48 ET | 748 | 8.23 |
11:50 ET | 275 | 8.2 |
11:52 ET | 4336 | 8.2 |
11:54 ET | 688 | 8.2 |
11:56 ET | 700 | 8.2 |
11:57 ET | 6245 | 8.17 |
11:59 ET | 870 | 8.17 |
12:01 ET | 2064 | 8.1471 |
12:06 ET | 983 | 8.15 |
12:08 ET | 19749 | 8.07 |
12:10 ET | 2555 | 8.13 |
12:12 ET | 777 | 8.1 |
12:14 ET | 100 | 8.11 |
12:15 ET | 993 | 8.1 |
12:17 ET | 2400 | 8.08 |
12:19 ET | 2638 | 8.08 |
12:21 ET | 415 | 8.0664 |
12:24 ET | 757 | 8.07 |
12:26 ET | 777 | 8.06 |
12:28 ET | 1488 | 8.05 |
12:30 ET | 200 | 8.03 |
12:32 ET | 1412 | 8 |
12:33 ET | 2833 | 8.015 |
12:35 ET | 300 | 8.01 |
12:37 ET | 500 | 8.01 |
12:39 ET | 4897 | 8.04 |
12:42 ET | 836 | 8.03 |
12:44 ET | 428 | 8.035 |
12:46 ET | 1474 | 8.04 |
12:48 ET | 1559 | 8.02 |
12:50 ET | 1962 | 8.04 |
12:51 ET | 1362 | 8.03 |
12:53 ET | 400 | 8.02 |
12:55 ET | 100 | 8 |
12:57 ET | 1386 | 8.005 |
01:00 ET | 1071 | 8.02 |
01:02 ET | 115 | 8.03 |
01:06 ET | 1849 | 8.015 |
01:08 ET | 2600 | 8 |
01:09 ET | 3344 | 8.05 |
01:11 ET | 4584 | 7.995 |
01:13 ET | 1610 | 7.99 |
01:15 ET | 805 | 8 |
01:18 ET | 5863 | 8.015 |
01:20 ET | 3072 | 8 |
01:22 ET | 600 | 8 |
01:24 ET | 5954 | 8.03 |
01:26 ET | 480 | 8.05 |
01:27 ET | 400 | 8.04 |
01:29 ET | 3528 | 8.045 |
01:31 ET | 700 | 8.05 |
01:33 ET | 100 | 8.045 |
01:36 ET | 2278 | 8.035 |
01:38 ET | 958 | 8.03 |
01:40 ET | 624 | 8.015 |
01:42 ET | 2685 | 8.03 |
01:44 ET | 964 | 8.01 |
01:45 ET | 979 | 8.01 |
01:47 ET | 800 | 8.01 |
01:49 ET | 1606 | 8.005 |
01:51 ET | 1102 | 7.9999 |
01:54 ET | 1232 | 8.005 |
01:56 ET | 1812 | 7.99 |
01:58 ET | 1600 | 7.975 |
02:00 ET | 916 | 7.985 |
02:02 ET | 1913 | 7.995 |
02:03 ET | 1885 | 7.985 |
02:05 ET | 3848 | 7.975 |
02:07 ET | 52603 | 7.985 |
02:09 ET | 1130 | 8.01 |
02:12 ET | 2659 | 8 |
02:14 ET | 14165 | 7.97 |
02:16 ET | 3045 | 7.94 |
02:18 ET | 700 | 7.93 |
02:20 ET | 12418 | 7.92 |
02:21 ET | 9594 | 7.925 |
02:23 ET | 700 | 7.92 |
02:25 ET | 1503 | 7.91 |
02:27 ET | 1648 | 7.91 |
02:30 ET | 14596 | 7.9 |
02:32 ET | 12645 | 7.88 |
02:34 ET | 4297 | 7.86 |
02:36 ET | 5442 | 7.86 |
02:38 ET | 2260 | 7.85 |
02:39 ET | 2657 | 7.85 |
02:41 ET | 5244 | 7.86 |
02:43 ET | 4900 | 7.92 |
02:45 ET | 4501 | 7.88 |
03:15 ET | 3403 | 8.015 |
03:17 ET | 5325 | 7.995 |
03:19 ET | 3037 | 8 |
03:21 ET | 2638 | 8.005 |
03:24 ET | 1300 | 8.005 |
03:26 ET | 100 | 8 |
03:28 ET | 44092 | 7.885 |
03:30 ET | 31545 | 7.91 |
03:32 ET | 200 | 7.895 |
03:33 ET | 9368 | 7.9 |
03:35 ET | 7077 | 7.94 |
03:37 ET | 4167 | 7.92 |
03:39 ET | 11334 | 7.955 |
03:42 ET | 5678 | 7.985 |
03:44 ET | 9836 | 7.935 |
03:46 ET | 10589 | 7.92 |
03:48 ET | 13740 | 7.925 |
03:50 ET | 4598 | 7.925 |
03:51 ET | 23722 | 7.915 |
03:53 ET | 7943 | 7.955 |
03:55 ET | 11275 | 7.935 |
03:57 ET | 28232 | 7.925 |
04:00 ET | 215072 | 7.93 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
89Bio Inc | 841.6M | -2.7x | --- |
Oruka Therapeutics Inc | 841.4M | -4.0x | --- |
Autolus Therapeutics PLC | 819.6M | -2.5x | --- |
Cullinan Therapeutics Inc | 803.6M | -4.8x | --- |
Nuvation Bio Inc | 885.2M | -1.2x | --- |
Tyra Biosciences Inc | 778.8M | -9.6x | --- |
89bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The Company’s lead product candidate, pegozafermin, a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG). Pegozafermin is engineered to protect against proteolysis and reduce renal clearance and optimize its potency, enabling the potential use of a lower dosage/dose. Pegozafermin has been optimally constructed with two mutations via substitutions with natural amino acids at site-specific positions (173 and 176) toward the C-terminus end of the hormone. It conducted a Phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics (PK) of pegozafermin.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $841.6M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 106.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.98 |
EPS | $-2.91 |
Book Value | $5.75 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.